AUG 06, 2020 7:27 AM PDT

Resetting the Body's Danger Sensor

WRITTEN BY: Tara Fernandez

The human body has a sophisticated danger-sensing mechanism that alerts the immune system when something is not right. This molecular sensor is called the inflammasome — a complex structure consisting of multiple proteins that send out chemical flares that trigger the immune system and protect sensitive tissues. Inflammasomes protect us from the constant barrage of environmental threats and invading pathogens. However, in the case of chronic diseases, the inflammasome’s warning signals get stuck in an on position, a dysfunctional state with devastating effects on human health.

Inflammasomes are receptors that are part of the innate immune system and work by regulating the activation of an enzyme called caspase-1. Once activated, caspase-1 initiates a flood of proinflammatory cytokines to the site, calling phagocytic immune cells such as macrophages to the scene to gobble up microbes and cellular debris to allow for healing and tissue restoration to begin.

While most of the danger sensors in the body are sensitive to bacteria and viruses, some respond to physiological changes in human cells: the formation of crystals, protein aggregates, and signs of damaged or stressed cells, for example. A growing body of evidence is pointing to just how important the inflammasome is in the development of conditions such as Alzheimer’s disease, cancer, and osteoarthritis, and how therapeutic strategies to turn off these proinflammatory signals may help patients find relief. 

In Alzheimer’s disease, the formation of amyloid plaques in brain tissues can set off inflammasomes in the brain, creating a constant state of inflammation that can exacerbate neural tissue damage and accelerate the patient’s cognitive decline. This vicious cycle is also observed in cancerous tissues, where tumor cells trigger the inflammasome, only to create an inflammatory microenvironment that allows tumors to grow and thrive.

Clinical strategies to block the signals that the inflammasome emits are now a major drug development focus for biopharma. Companies such as IFM Therapeutics specialize in creating ways of targeting and modulating the innate immune system when it is overactive in disease states such as autoimmune disorders and cancer. Inflammasome therapies are currently in early-stage clinical trials, with many more in the pipeline to treat an array of chronic diseases.

 

 

Sources: Nature, Novartis, Molecular Cancer.




 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 10, 2021
Immunology
An Immune Molecule Helps Create 'Good' Fat
AUG 10, 2021
An Immune Molecule Helps Create 'Good' Fat
Not all fat is ‘bad’—there’s white fat that builds up when excess calories are consumed. But, th ...
AUG 31, 2021
Health & Medicine
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
AUG 31, 2021
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
Consider yourself among the luckiest if you made a full recovery from infection with SARS-CoV-2, especially if you were ...
SEP 07, 2021
Health & Medicine
Think you can pay back your sleep debt this weekend? Think again.
SEP 07, 2021
Think you can pay back your sleep debt this weekend? Think again.
Researchers find that even one night of sleep loss results in impaired functioning and well being.
SEP 14, 2021
Immunology
Extinguishing Fires in the Brains of MS Patients
SEP 14, 2021
Extinguishing Fires in the Brains of MS Patients
  A closer look at the brains of patients with aggressive, debilitating forms of multiple sclerosis (MS) reveals so ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
Loading Comments...